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Abstract
Background: Bovine babesiosis is a tick-borne disease caused by several species of Babesia which produce acute
and fatal disease in cattle and affect livestock industry worldwide. Babesia ovata is a benign species widespread in
east Asian countries and causes anemia, particularly in cattle which are co-infected with Theileria orientalis. The
development of genetic manipulation methods is necessary to improve our understanding of the basic biology of
protozoan pathogens toward a better control of disease. Such tools have not been developed for B. ovata, and are
the aim of this study.
Methods: In this study we transfected constructs that were designed to evaluate the ability of several B. ovata
promoter candidates to drive expression of a reporter luciferase. We found that the elongation factor-1 alpha
intergenic region (ef-1α IG) and the actin 5’ non-coding region (NR) had highest promoter activities. To establish a
stable transfection system, we generated a plasmid construct in which the ef-1α IG promoter drives gfp expression,
and the actin 5’ NR mediates expression of the selectable marker hdhfr. The plasmid was designed for episomal
transfection, as well as to integrate by double cross-over homologous recombination into the ef-1α locus. Circular
or linearized plasmid was transfected by electroporation into in vitro cultured B. ovata and retention of the plasmid
was facilitated by drug selection with 5 nM WR99210 initiated 48 h after transfection.
Results: After one-week cultivation with WR99210, GFP-expressing parasites were observed by fluorescence
microscopy. Integration of the plasmid construct into the ef-1α locus was confirmed by PCR, Southern blot analysis,
and sequencing of recombination sites. These results confirm successful development of a stable transfection
system for B. ovata.
Conclusion: The current study provides a fundamental molecular tool to aid in molecular and cellular studies of B.
ovata.
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Background
Bovine babesiosis remains an economic burden in live-
stock industry worldwide and is caused by intraerythro-
cytic apicomplexan parasites of the genus Babesia. The
most common and pathogenic species of Babesia in-
fecting cattle are Babesia bovis, B. bigemina and B.
divergens, whose geographical distributions are defined
by the prevalence of their respective tick vectors. B.
ovata is a benign bovine Babesia sp. widespread in
several east Asian countries [1] and causes anemia par-
ticularly in animals co-infected with Theileria orientalis,
since both parasites are transmitted by the ixodid tick,
Haemaphysalis longicornis [2].
Obstacles to control bovine babesiosis include the lack
of effective and safe vaccines, the emergence of
acaricide-resistant ticks [3], limited choices for anti-
Babesia drugs in the field, and the emergence of drug-
resistant Babesia strains [4]. Better understanding of the
basic biology of Babesia spp. is crucial to design and de-
velop new strategies for controlling the disease. In the
post-genomic era in which the genome sequence infor-
mation for several Babesia spp. is available, genetic ma-
nipulation using reverse genetic techniques can improve
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our understanding of the basic biology of these parasites.
Transfection systems have been established for several
apicomplexan parasites such as Plasmodium falciparum
[5], Toxoplasma gondii [6], Babesia bovis [7, 8] and re-
cently Theileria parva [9]. Regarding Babesia spp., only
two reports describe stable transfection systems, for B.
bovis [7, 8]; one used blasticidin-S/blasticidin deaminase
and the other employed WR99210/human dihydrofolate
reductase (hdhfr) as selective markers.
Several Babesia spp. are responsible for babesiosis in
cattle causing a range of clinical symptoms from acute
severe anemia and occasionally death by B. bigemina
and B. bovis to a mild anemia or subclinical signs by B.
ovata. Our group has recently derived whole genome
nucleotide sequence for B. ovata (unpublished data).
This advancement, together with the availability of gen-
ome sequences from other pathogenic bovine Babesia
spp. [10–12], paves the way for comparative functional
genomics studies and to find genes responsible for the
virulence and pathogenesis of these parasites. To aid in
these molecular and cellular studies, we describe herein
the development of a transfection system for B. ovata.
Since B. ovata infection is benign and does not cause
severe clinical symptoms in cattle, stable integration of
expression vectors could be used to transfer an
immunogenic antigen of pathogenic Babesia spp. and in-
duce protective antibody against virulent bovine Babesia
spp. In addition, H. longicornis, the tick vector for B.
ovata, is easily maintained in vitro and has been used to
study the biology of ixodid ticks [13]. Therefore, B. ovata
could be employed as a model organism to study the
tick stage of Babesia, the genes responsible for tick
transmission as well as parasite and tick interactions.
Since the elongation factor-1 alpha intergenic region
(ef-1α IG) and the actin 5’ non-coding region (NR) con-
tain promoter activities which conferred expression of a
reporter protein in B. bovis [8, 14], we initially attempted
to use these B. bovis promoters for transfection of B.
ovata. However, these trials were not successful (unpub-
lished data), suggesting that B. bovis promoters might
not work in B. ovata. Therefore, in this study, we ini-
tially evaluated several B. ovata promoter candidates and
then established a stable transfection system for this
parasite using selected strongest promoters.
Methods
Parasite culture
The B. ovata Miyake strain was cultured in vitro using
purified bovine red blood cells (RBCs) purchased from
Nippon Bio-Test Laboratories (Tokyo, Japan) and GIT
medium (Wako Pure Chemical Industries, Osaka, Japan)
in a microaerophilous stationary phase system as de-
scribed [15].
Evaluation of sensitivity of B. ovata to WR99210
B. ovata was cultured in 1 ml culture medium contain-
ing 10 % bovine RBC in a 24-well plate with or without
WR99210 (0, 0.5, 1, 5, 10 and 50 nM). The initial para-
sitemia was 0.5 % and the final parasitemia was mea-
sured on day 3. For each drug concentration, parasites
were cultured in triplicate and culture medium was re-
placed daily. Parasitemia was calculated by examining
5000 RBCs of a prepared thin blood smear stained with
Giemsa's solution.
Plasmid constructs
For evaluation of promoter activity, the firefly luciferase
gene was amplified by PCR from the plasmid pEN-
T12luc using specific primers (Additional file 1: Table
S1) and inserted into the EcoRV site of pBluescript plas-
mid vector using an In-Fusion HD Cloning Kit (Takara
Bio Inc., Otsu, Japan) (Fig. 1a). The B. ovata rhoptry as-
sociated protein-1 intergenic region (rap-1 IG) was amp-
lified by PCR from B. ovata genomic DNA using specific
primers and inserted into the BamHI site of pBluescript.
The B. ovata ef-1α IG, 5’ NR of actin, heat shock protein
70 (hsp70), calmodulin (cam), thioredoxin peroxidase
1(tpx-1) and B. bovis ef-1α IG were amplified by PCR
and cloned into the HindIII site of pBluescript to be
evaluated for their promoter activities. To construct an
internal control plasmid to normalize the promoter ac-
tivity, a DNA fragment encoding Renilla reniformis lucif-
erase was amplified from pHRH (a gift from Dr. Kirk
Deitsch, Weill Cornell Medical College, USA) using spe-
cific primers (Additional file 1: Table S1) and inserted
into the EcoRV site of pBluescript plasmid vector
(Fig. 1a). Renilla luciferase was driven by ef-1α IG2 and
rap-1 IG used as terminator. The sequences from all
novel candidate promoters were deposited in DDBJ/
EMBL/GenBank nucleotide database with the accession
numbers LC101765-69.
A schematic diagram of GFP-expressing plasmid (pBS-
EGRADE) is shown in Fig. 2a. The plasmid was designed
for episomal transfection as well as integration into the
ef-1α locus of B. ovata. The drug selection and reporter
gene cassettes were separated in order to drive hdhfr
and gfp with different promoters. All the PCR primers
used for plasmid construction are listed in Table 1 and
the restriction sites are underlined. To construct the re-
porter cassette, gfp was amplified from a B. bovis GFP
expressing plasmid [8] and cloned into the HindIII site
of pBluescript using an In-Fusion HD Cloning Kit. To
produce a strongly expressing GFP parasite, the ef-1α
IG2 which showed strong promoter activity by luciferase
assay was cloned into a ClaI site at the 5’ flanking region
of gfp. B. ovata rap-1 IG was cloned into an EcoRV site
at the 3’ flanking region of gfp. For construction of the
drug selection cassette, hdhfr was amplified from a B.
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bovis GFP-expressing plasmid [8] and cloned into the
BamHI site of pBluescript. The hdhfr gene was flanked
by actin 5’ NR and ef-1α 3’ NR at the 5’ and 3’ flanking
regions, respectively. The resulting hdhfr expression cas-
sette was amplified with a primer pair, BoADE-F-EcoRI-
IF and BoADE-R-EcoRI-IF (Table 1), and cloned into the
EcoRI site of the reporter cassette to produce the pBS-
EGRADE plasmid. All plasmids were purified using a
Qiagen Plasmid Maxi kit (Qiagen, MD, USA) following
the manufacturer’s instructions and the inserted DNA
sequences were confirmed by sequencing. The sequence
of pBS-EGRADE was deposited into DDBJ/EMBL/Gen-
Bank nucleotide database with the accession number
LC101772.
Transfection of parasites
To prepare B. ovata-infected RBCs (iRBCs) for transfec-
tion, cell pellets were washed twice with PBS and one
time with cytomix buffer (120 mM KCl, 0.15 mM CaCl2,
10 mM K2HPO4, 10 mM KH2PO4, 25 mM HEPES,
pH 7.6, 2 mM EGTA, 5 mM MgCl2, 100 μg/ml bovine
serum albumin, and 1 mM hypoxanthine). One hundred
microgram of the circular plasmid in 50 μl of cytomix
was mixed with 50 μl of Amaxa nucleofector human T-
cell solution, and then combined with 100 μl of washed
iRBCs. To promote genome integration of the plasmid
in order to produce B. ovata stably expressing GFP, the
pBS-EGRADE plasmid was linearized by incubating
overnight with SalI and SacII. The resulting linear plas-
mid would favor integration into the ef-1α locus of B.
ovata. Parasite-iRBCs were transfected with the circular
or linearized plasmids by electroporation using a nucleo-
fector device with a program v-024 (Amaxa Biosystems,
Cologne, Germany) [8] and were immediately transferred
to 1 ml culture containing 10 % of bovine RBCs. To se-
lect GFP-expressing transgenic parasites, WR99210 was
added two days after the transfection. The parasite
population transfected with the linearized plasmid was
cloned by limiting dilution.
Luciferase assay
A luciferase assay was performed to evaluate activities of
candidate promoters. Transient transfections were con-
ducted by introducing 50 μg of each promoter plasmid
expressing firefly luciferase together with 50 μg of renilla
luciferase-expressing plasmid into B. ovata-iRBCs. The
luciferase assay was performed 48 h after transfection. A
parasite pellet was prepared for the luciferase assay as
described [16] and resuspended in 230 μl of freshly-
prepared Promega’s 1X cell culture lysis reagent (Pro-
mega, Madison, WI, USA). The pellet was incubated for
15 min at room temperature (RT) for complete lysis and
briefly centrifuged to remove the cell debris. Seventy-
five microliters of cell lysate were mixed with 75 μl of
the Dual-Glo luciferase substrate. The mixture was kept
for 10 min at RT and the luminescence was measured
for 10 s using a microplate reader (Wallac 1420; Perki-
nElmer, Turku, Finland). Immediately after measurement
of firefly luciferase activity, 75 μl of Dual-Glo Stop &
Glo reagent was added to each well of the plate. Renilla
luciferase activity was measured after 10 min incubation
at RT. Readings from mock transfected parasites were
subtracted from the firefly and renilla luciferase readings
and the resulting values of firefly luciferase activity were
normalized using the renilla luciferase activity for each
sample. To evaluate promoter activities, three independ-
ent transfections were done for each promoter and each
luciferase assay was performed in triplicate.
















Restriction enzyme sites are underlined
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Biostatistical analysis of promoter activities
The normalized luciferase activities were plotted using
GraphPad Prism6. Activity of each promoter candidates
was examined by Dunnett’s multiple comparison test
with a promoter-less (control) plasmid. The promoter
activity was considered to be significantly different from
the control if P-value was below 0.05.
PCR to confirm the integration of pBS-EGRADE into ef-1α
locus
Three sets of primers were designed to confirm the inte-
gration of pBS-EGRADE into the ef-1α locus by specific
amplification of DNA fragments surrounding the 5’ re-
combination site, the 3’ recombination site and the ef-1α
locus (Additional file 1: Table S1). To examine the 5’
recombination event of the plasmid construct, a primer
pair Boef1α-integ-F and eGFP-R-HindIII-IF was used to
amplify a 2.2 kb DNA fragment. To confirm the 3’ re-
combination event of the plasmid construct, a primer
pair hDHFR-F-BamHI-IF and Boef1α-integ-R was used
to amplify a 1.8 kb DNA fragment. To examine if the
ef-1α gene was replaced with the plasmid construct, a
primer pair Boef1α-F2 and Boef1α-integ-R was used, by
which a 7.7 kb DNA fragment would be amplified for
the pBS-EGRADE-integrated parasites or a 3.6 kb DNA
fragment for the wild type and episomally transfected
parasites. The nucleotide sequences of the amplified
DNA fragments containing the 5’ or 3’ recombination
sites were confirmed by sequencing.
Southern blot analysis
Genomic DNA was extracted from wild type and 2 para-
site isolates transfected with linearized pBS-EGRADE.
Five micrograms of DNA were digested overnight with
100 units of NotI and PacI, separated by agarose gel elec-
trophoresis and transferred onto HyBond N+ (GE Health-
care, Buckinghamshire, UK). Two probes were used, one
corresponding to the complete open reading frame (ORF)
of gfp and the other 1 kb length of ef-1α 3’NR, and were
labeled and hybridized with the AlkPhos Direct kit (GE
Healthcare) according to the manufacturer’s instructions.
The signal was developed with CDP-star detection reagent
(GE Healthcare) and detected with a multipurpose CCD
camera system (LAS-4000 mini EPUV; Fujifilm, Japan).
Results
Evaluation of the B. ovata promoter activities
In order to evaluate promoter activity and to select
promoters to be used for stable transfections, candidate
promoters were chosen which were previously used for
B. bovis or Plasmodium. The evaluated candidate pro-
moters were (i) ef-1α IG, which has a bidirectional pro-
moter activity in B. bovis [17]; (ii) actin 5’NR, which
showed strong promoter activity in B. bovis [8]; (iii) tpx-
1 5’NR, which was shown to constitutively express in
Plasmodium spp. [18, 19]; and (iv) cam 5’NR and hsp70
5’NR, which were used for P. falciparum [5, 20]. Similar
to the B. bovis ef-1α gene locus [17], two ef-1α gene cop-
ies are oriented head to head in the B. ovata genome,
and thus the IG region was expected to have a bidirec-
tional promoter activity. To independently evaluate the
two promoter activities in the ef-1α IG region, two plas-
mids termed IG1 and IG2 were constructed (Fig. 1c).
Our initial analysis of rap-1 region in B. ovata revealed
at least three copies of rap-1a and rap-1b in the genome.
This architecture is similar to what was observed for the
B. bigemina genome in which five copies of rap-1a and
rap-1b are tandemly arranged and an additional copy of
rap-1b and a copy of rap-1c are located at 3’ of these
gene loci [21]. The intergenic region between rap-1a
and rap-1b which contains the 3’ NR of rap-1a was
selected as a terminator.
In the initial trials for transient transfection, we intro-
duced 50 μg of plasmid constructs with transfection
conditions of low voltage/high capacitance (0.31 kV, 1
mF) or high voltage/low capacitance (1.25 kV, 25 μF)
using a Gene Pulser Xcell apparatus (Bio-Rad,
Richmond, CA) [14]. Parasite lysates did not show any
luciferase activity indicating the failure in introducing
plasmid into the parasite using these conditions, possibly
due to harmful effects of electroporation to the parasites.
Because P. falciparum is able to uptake plasmid DNA
and efficiently express exogenous proteins following in-
fection of erythrocytes which are preloaded by electro-
poration into the RBC cytosol [22], we preloaded 50 μg
of plasmid DNA to the bovine RBCs for the transfection
experiment. Again, however, parasite lysates did not
show any luciferase activity after this procedure. The
erythrocytic cycle of B. ovata (7–10 h) [23] is shorter
than that of P. falciparum (48 h), which might be the
reason for the failure of the transfection with plasmid-
preloaded RBC. In a third attempt nucleofection using
an Amaxa nucleofector device with 50 μg of plasmid
DNA was successful for transient expression experi-
ments (data not shown). Increasing plasmid DNA to
100 μg showed more efficient transformation and was
used for the evaluation of promoter activity and stable
transfection.
We first determined the best time for evaluation of the
promoter activity for B. ovata using a plasmid expressing
luciferase driven by the B. ovata actin 5’NR. Parasite
lysates were prepared at 24, 48, 72 and 96 h post trans-
fection for the luciferase assay. We found that while
parasites transfected with a promoter-less construct
(negative control) did not show luciferase activity, the
peak of luciferase activity for actin 5’NR was at 48 h post
transfection; thus we selected this time point to evaluate
luciferase activities (Fig. 1b). Simultaneous expression of
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firefly luciferase under different promoters and renilla
luciferase under the identical promoter in Plasmodium
spp. enables to normalize the firefly luciferase value
using renilla luciferase value as a transfection efficiency
control [20, 24]. Therefore, firefly luciferase lumines-
cence values were normalized with the renilla luciferase
values from the same samples. By three independent
transfection experiments, ef-1α IG2 and actin 5’NR
showed significantly higher values than promoter-less
(control) plasmid (P < 0.001), whereas the luciferase
values from hsp70 5’NR, tpx-1 5’NR, cam 5’NR and ef-
1α IG1 were not significantly different when compared
to the control (P > 0.05) (Fig. 1c). The B. bovis ef-1α IG
construct, for which a promoter activity was validated in
B. bovis [8], was not able to express firefly luciferase in B.
ovata, indicating that B. bovis ef-1α IG was not recognized
by the B. ovata transcriptional or translational machinery.
Growth of B. ovata is inhibited by WR99210 at nanomolar
concentration
WR99210 has been successfully used to select for stable
transfection of B. bovis [8]. To examine whether
WR99210 could inhibit the growth of B. ovata at low
concentration, and to determine a suitable concentration
to select the transgenic parasites, B. ovata was cultured
in the presence of different concentrations of WR99210
from 0 to 50 nM. The experiment was done in triplicate
wells and parasitemia was calculated on day 3 after
adding the drug into the culture (Fig. 2b). The calculated
IC50 was 0.56 ± 0.01 nM and 5 nM WR99210 completely
inhibited the growth of B. ovata; thus we employed 5
nM thereafter for the selection of stable GFP-expressing
parasites.
Establishment of the B. ovata line stably expressing GFP
Approximately one week after addition of WR99210,
GFP-expressing parasites appeared in cultures which
were transfected with either circular or linearized plas-
mids (Fig. 2c). The integration of pBS-EGRADE into the
ef-1α locus was initially evaluated by PCR. The diagnos-
tic PCR-1 and −2 primer pairs successfully amplified 2.2
and 1.8 kb DNA fragments, respectively, using DNA
template from genome integrated (GI) isolates; and the
amplified DNA fragments were validated by sequencing
(Fig. 3a). These DNA fragments sequences were depos-
ited into DDBJ/EMBL/GenBank nucleotide database
with the accession numbers LC101770 and LC101771.
No amplified products were detected using DNA tem-
plate from episomal transfectants or wild type parasites.
In addition, PCR-3 primer pair amplified a 7.7 kb DNA
fragment, a size expected after the insertion of the pBS-
EGRADE construct into the ef-1α locus. In contrast, a
3.6 kb DNA fragment was amplified for wild type and
episomal transfectants, indicating that their ef-1α locus
was intact. Overall, the PCR results confirmed the inte-
gration of the plasmid construct into the ef-1α locus in
the GI1 and GI2 parasite lines. We further confirmed
Fig. 1 Schematic diagram of the plasmids used for transient transfection and evaluation of promoter activity. a Plasmid construct to evaluate the
promoter activity and a Renilla luciferase-expressing plasmid for normalization. b Evaluation of the promoter activity of actin 5’NR driving
luciferase expression, over a time course of 24–96 h post transfection. c Comparison of luciferase activity in lysates of B. ovata transfected with
different constructs at 48 h post transfection. A promoter-less plasmid was used as a negative control. Values from 3 independent transfections
are shown. Asterisks indicate statistical significance between promoter-less plasmid (No Promoter) and other promoter candidates by Dunnett’s
multiple comparison test (p < 0.001). RLU: Relative luciferase units
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Fig. 3 Confirmation of the integration of pBS-EGRADE into the ef-1α locus. a Schematic diagram and PCRs to confirm the integration of pBS-
EGRADE into ef-1α locus. PCR-1, −2 and −3 are done with primer sets Boef1α-integ-F/eGFP-R-HindIII-IF, hDHFR-F-BamHI-IF/Boef1α-integ-R and
Boef1α-F2/Boef1α-integ-R, respectively. b Schematic diagram and Southern blot analysis to confirm the integration of pBS-EGRADE into ef-1α
locus. Five microgram of samples genomic DNA were digested with PacI and NotI, and hybridized with gfp and ef-1α 3’NR probes. GI: genome
integrated; Episomal: two independent transfectants with circular plasmids; WT: wild type
Fig. 2 Schematic diagram of GFP-expressing plasmid construct, growth inhibition of B. ovata by WR99210 and fluorescence microscopy images
of stably expressing GFP B. ovata. a Plasmid construct for stable GFP expression (pBS-EGRADE) showing the recombination sites for integration
into the ef-1α locus by homologous double cross-over recombination. The restriction sites for linearization (SalI and SacII) are shown. b Growth
inhibition rate of B. ovata in the absence or presence of different concentrations of WR99210. All data are expressed as mean + SEM of triplicate
culture. c Live fluorescence microscopy images of GFP-expressing parasites. The pictures are taken from the pBS-EGRADE genome integrated
isolate 1. The parasite nucleus was stained with Hoechst33342. Scale-bar: 10 μm
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the structure of the integration site by Southern blot
analysis (Fig. 3b). The gfp and ef-1α 3’NR probes both
detected a single 8.9 kb band for GI isolates 1 and 2,
while only the ef-1α 3’NR probe detected a single 4.8 kb
band and the gfp probe did not detect any band for wild
type parasites. These results confirmed the correct
integration of pBS-EGRADE into the ef-1α locus. In
addition, the growth of GI isolates was comparable with
wild type parasites, indicating that disruption of one
copy of the ef-1α gene did not affect the growth of para-
sites in the in vitro culture condition (Fig. 4).
Discussion
In this study we transiently introduced plasmid DNA
into B. ovata in order to evaluate promoter activity.
With this transient expression we evaluated the strength
of promoter activity for a panel of B. ovata promoters,
as well as for the B. bovis ef-1α IG promoter region.
Evaluation of a range of promoter types and activities in-
creases the options of promoters to be chosen to express
transgenes in accordance the purposes of a given study.
Herein, we aimed to establish a transfection system
using GFP as a reporter protein, and therefore the ef-1α
IG2 was chosen to drive gfp and the actin 5’NR to drive
hdhfr based upon their relatively strong promoter activ-
ities. Unlike Plasmodium spp., for which ef-1α promoter
region from one species works in other species, the B.
bovis ef-1α IG promoter region was not able to express
luciferase in B. ovata, and this indicates that B. bovis
ef-1α IG was not recognized by B. ovata’s transcription
or translation system.
The first report of stable transfection of B. bovis tar-
geted the ef-1α locus for genome integration of a plas-
mid construct [7]. Preliminary investigation of the ef-1α
locus sequence in B. ovata showed that two identical
genes are located head to head and are separated by a
1.4 kb IG region (unpublished data), similar to the
pattern reported for B. bovis and Plasmodium [17, 25].
Replacing one of two ef-1α in Plasmodium or B. bovis by
homologous recombination did not significantly affect
the growth of the parasites [7, 26, 27] and thus we con-
sidered that one of the ef-1α gene loci could be targeted
as an integration site of exogenous genes into the gen-
ome. As expected, we were able to use this gene locus
for the genome integration in B. ovata, and destruction
of one of the ef-1α gene loci did not affect the growth of
GI isolates, suggesting the feasibility of this locus as a
site for the introduction of foreign genes.
For the selection of GFP-expressing parasites we
employed hdhfr as a selectable marker which confers re-
sistance to WR99210 and pyrimethamine [28]. It was re-
ported that in most cases the selection of B. bovis using
hdhfr/pyrimethamine resulted in the selection of natur-
ally resistant parasites, which challenged the use of this
selection system for B. bovis [14]. However, the hdhfr/
WR99210 system was successfully employed for B. bovis
in our former study, in which natural resistant parasites
were not selected [8]. Thus we used WR99210 instead of
pyrimethamine. The IC50 of WR99210 against B. ovata
was 0.56 ± 0.01 nM, which is comparable to that of B.
bovis (1 nM) [8]. The transfectants selected with hdhfr/
WR99210 in this study emerged as early as 7 days after
adding the drug and continued expressing GFP for more
than 7 months after transfection (data not shown), indi-
cating the feasibility of using this selection system for B.
ovata.
In a recent report two selection systems, blasticidin-S/
blasticidin deaminase and WR99210/hdhfr, were suc-
cessfully used sequentially in a double transfection sys-
tem for complementation of tpx-1 gene knockout and
Fig. 4 Growth curve of different lines of B. ovata. Wild type (WT) and genome integrants (GI) were cultured continuously by sub-culturing every
3 days and parasitemia monitored daily
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subsequent recovery of the phenotype for B. bovis [29].
This method could be used not only for gene knockout
complementation studies but also for the development
of double gene knockouts to investigate biological as-
pects of this parasite, such as invasion and egress, where
multiple genes may be involved. In addition, the avail-
able gene knockout technologies for T. gondii and P.
falciparum were further advanced by the CRISPR/Cas9-
based genome editing strategy [30, 31]. The CRISPR/
Cas9 system has also been successfully employed for
genetic modification of the diarrheal protozoan parasite,
Cryptosporidium parvum [32], indicating the feasibility
of this genome editing system in various organisms.
These developments together with conditional systems
for regulation of gene expression at the genomic, tran-
scriptional or protein level could be applied for Babesia
spp. to investigate genes responsible for survival, viru-
lence, transmission and immunity of bovine babesiosis.
Conclusion
Here, we established a transient and stable transfection
systems for B. ovata and successfully inserted a foreign
gene via integration and disruption of one copy of the
ef-1α gene. This advancement in methodology enables
us to investigate gene functions in B. ovata by targeted
gene disruption, complementation and tagging of target
proteins.
Additional file
Additional file 1: Table S1. List of primers used for promoter
evaluation constructs and PCRs to confirm the integration of
pBS-EGRADE into ef-1α locus. (PDF 162 kb)
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